X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - HEALTHTECHZONE.COM - Medical Devices - 26/Sep 21:10

Qualigen Therapeutics, Inc. Announces management changes.

Articles similaires

Sorry! Image not available at this time

Franklin Resources, Inc. Announces Month-End Assets Under Management

healthtechzone.com - 11/Nov 21:01

Sorry! Image not available at this time

Franklin Resources, Inc. Announces Month-End Assets Under Management

healthtechzone.com - 11/Nov 21:01

Sorry! Image not available at this time

Investcorp Credit Management BDC, Inc. Announces Financial Results for the Quarter Ended September 30, 2024, and Quarterly Distribution

healthtechzone.com - 13/Nov 03:45

Sorry! Image not available at this time

Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

drugs.com - 12/Nov 20:11

CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the U.S. Food and Drug Administration (FDA)...

Sorry! Image not available at this time

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease

drugs.com - 18/Nov 19:11

LEXINGTON, Mass.--(BUSINESS WIRE)--Nov. 18, 2024-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug...

Sorry! Image not available at this time

Renesas Announces Additional Key Leadership Changes

healthtechzone.com - 06/Nov 05:00

Sorry! Image not available at this time

Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

healthtechzone.com - 07/Nov 12:00

Sorry! Image not available at this time

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

healthtechzone.com - 13/Nov 12:00

Sorry! Image not available at this time

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 11/Nov 03:11

LOS ALTOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Sorry! Image not available at this time

Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

drugs.com - 12/Nov 18:11

CHICAGO and FORT WORTH, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the...

Les derniers communiqués